Adibah Ali1, Miguel Debono2, Sabapathy P Balasubramanian3,4. 1. Endocrine Surgery Unit, Sheffield Teaching Hospitals NHS Foundation Trust, F8, Ward F2, Royal Hallamshire Hospital, Beech Hill Road, Sheffield, S10 2JF, UK. 2. Department of Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. 3. Endocrine Surgery Unit, Sheffield Teaching Hospitals NHS Foundation Trust, F8, Ward F2, Royal Hallamshire Hospital, Beech Hill Road, Sheffield, S10 2JF, UK. s.p.balasubramanian@sheffield.ac.uk. 4. Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. s.p.balasubramanian@sheffield.ac.uk.
Abstract
BACKGROUND: Surgery for Graves' disease (GD) is usually performed after adequate control with medical treatment. Occasionally, rapid pre-operative optimization is required. The primary objective was to compare the outcomes of patients undergoing elective surgery for well-controlled GD with those undergoing rapid pre-operative treatment. We also propose a formal treatment protocol for future use. METHODS: A retrospective cohort study in a tertiary referral centre included 247 patients with well-controlled GD undergoing elective surgery and 19 patients with poorly controlled disease undergoing surgery after rapid optimization. The latter group did not respond well to thionamides (carbimazole and/or propylthiouracil) or had intolerance or side effects to thionamides and were treated with a range of non-thionamide drugs, including Lugol's iodine, cholestyramine, beta blockers and steroids (with or without thionamides), and closely monitored for 1-2 weeks before surgery. Outcome measures included thyroid storm, hypoparathyroidism and recurrent laryngeal nerve palsy. RESULTS: In total, 266 patients with male-to-female ratio of 1:6 and median (interquartile range) age of 39 (31-51) were included. Overall, long-term recurrent laryngeal palsy and hypoparathyroidism occurred in 1 (0.38%) and 13 (4.9%) patients, respectively. No patient had thyroid storm. There was no significant difference in hypoparathyroidism (p = 1), vocal cord palsy (p = 0.803) and post-operative bleeding (p = 0.362), between elective surgery and rapid optimization groups. CONCLUSION: Rapid pre-operative treatment is effective, safe and is associated with similar outcomes compared to usual treatment. A rapid pre-operative optimization protocol is proposed.
BACKGROUND: Surgery for Graves' disease (GD) is usually performed after adequate control with medical treatment. Occasionally, rapid pre-operative optimization is required. The primary objective was to compare the outcomes of patients undergoing elective surgery for well-controlled GD with those undergoing rapid pre-operative treatment. We also propose a formal treatment protocol for future use. METHODS: A retrospective cohort study in a tertiary referral centre included 247 patients with well-controlled GD undergoing elective surgery and 19 patients with poorly controlled disease undergoing surgery after rapid optimization. The latter group did not respond well to thionamides (carbimazole and/or propylthiouracil) or had intolerance or side effects to thionamides and were treated with a range of non-thionamide drugs, including Lugol's iodine, cholestyramine, beta blockers and steroids (with or without thionamides), and closely monitored for 1-2 weeks before surgery. Outcome measures included thyroid storm, hypoparathyroidism and recurrent laryngeal nerve palsy. RESULTS: In total, 266 patients with male-to-female ratio of 1:6 and median (interquartile range) age of 39 (31-51) were included. Overall, long-term recurrent laryngeal palsy and hypoparathyroidism occurred in 1 (0.38%) and 13 (4.9%) patients, respectively. No patient had thyroid storm. There was no significant difference in hypoparathyroidism (p = 1), vocal cord palsy (p = 0.803) and post-operative bleeding (p = 0.362), between elective surgery and rapid optimization groups. CONCLUSION: Rapid pre-operative treatment is effective, safe and is associated with similar outcomes compared to usual treatment. A rapid pre-operative optimization protocol is proposed.
Authors: H Yamashita; T Murakami; S Noguchi; M Shiiba; S Watanabe; S Uchino; H Kawamoto; M Toda; N Murakami Journal: Ann Surg Date: 1999-02 Impact factor: 12.969
Authors: Gustavo A Rubio; Tulay Koru-Sengul; Tanaz M Vaghaiwalla; Punam P Parikh; Josefina C Farra; John I Lew Journal: Thyroid Date: 2017-05-22 Impact factor: 6.568
Authors: Abrar Al Jassim; Tim Wallace; Sarah Bouhabel; Agnieszka Majdan; Michael Hier; Veronique-Isabelle Forest; Richard Payne Journal: J Otolaryngol Head Neck Surg Date: 2018-05-21